Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
Journal article published in 2016 by
Jon Bjoern,
Trine Zeeberg Iversen,
Nikolaj Juul Nitschke,
Mads Hald Andersen,
Inge Marie Svane
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 